Clinical trial
Six-month Endothelial and Microcirculatory Function of the Bioactive Sirolimus-eluting Combo Stent Versus the Polymer-free Biolimus-eluting Biofreedom Stent in Patients With ST-segment Elevation Myocardial Infarction
NCT04202172 is registered in ClinicalTrials.gov with Institut d'Investigació Biomèdica de Bellvitge as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Six-month Endothelial and Microcirculatory Function of the Bioactive Sirolimus-eluting Combo Stent Versus the Polymer-free Biolimus-eluting Biofreedom Stent in Patients With ST-segment Elevation Myocardial Infarction
- Lead sponsor
- Institut d'Investigació Biomèdica de Bellvitge
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 5, 2018
- Completion date
- September 1, 2020
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary microvascular disease, endothelial dysfunction, myocardial infarction